Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


A Pilot Test of t:Slim X2 With Control-IQ Technology
Condition:   Type1 Diabetes Mellitus
Intervention:   Device: Tandem t:slim X2 with Control-IQ Technology
Sponsors:   University of Virginia;   Tandem Diabetes Care, Inc.;   DexCom, Inc.;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Mon, 11 Dec 2017 12:00:00 EST


Accuracy, Satisfaction and Usability of a FGM System Among Children and Adolescents Attending a Diabetes Summer Camp
Condition:   Type 1 Diabetes Mellitus
Intervention:   Device: Flash Glucose Monitoring
Sponsors:   University of Lausanne Hospitals;   University Hospital, Geneva
Completed

Mon, 11 Dec 2017 12:00:00 EST


Assessment of Mealtime Bolus Insulin Behavior
Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Interventions:   Device: Continuous Glucose Monitoring;   Drug: Insulin Lispro
Sponsor:   Eli Lilly and Company
Not yet recruiting

Mon, 11 Dec 2017 12:00:00 EST


Caffeine Consumption and Mortality in Diabetes
Condition:   Diabetes Mellitus
Intervention:  
Sponsor:   João Sérgio Neves
Completed

Mon, 11 Dec 2017 12:00:00 EST


High-fat Overfeeding, Hepatokines and Appetite Regulation
Conditions:   Insulin Resistance;   Type2 Diabetes Mellitus;   Non-Alcoholic Fatty Liver Disease;   Obesity
Intervention:   Dietary Supplement: High-fat diet
Sponsors:   Loughborough University;   Nottingham Trent University;   Nottingham University Hospitals NHS Trust
Recruiting

Mon, 11 Dec 2017 12:00:00 EST


Noninvasive Glucose Measurements - Database and Calibration Compilation
Condition:   Diabetes
Intervention:   Device: WM3.4
Sponsor:   RSP Systems A/S
Terminated

Mon, 11 Dec 2017 12:00:00 EST


Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health
Condition:   Overweight and Obesity
Interventions:   Behavioral: One-on-one Session;   Behavioral: Self-monitoring;   Behavioral: Feedback
Sponsor:   University of Pittsburgh
Not yet recruiting

Mon, 11 Dec 2017 12:00:00 EST


The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
Conditions:   Atherosclerosis;   Dyslipidemias;   Diabetes
Interventions:   Drug: Prednisone 20 Mg;   Drug: Prednisone 40 Mg
Sponsor:   Prof. Tony hayek MD
Not yet recruiting

Mon, 11 Dec 2017 12:00:00 EST


A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
Conditions:   IgA Nephropathy;   CKD Associated With Type 1 Diabetes;   Focal Segmental Glomerulosclerosis;   Autosomal Dominant Polycystic Kidney
Intervention:   Drug: Bardoxolone methyl capsules
Sponsor:   Reata Pharmaceuticals, Inc.
Not yet recruiting

Fri, 08 Dec 2017 12:00:00 EST


A Study of LY3209590 in Participants With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: LY3209590;   Drug: Insulin Glargine
Sponsor:   Eli Lilly and Company
Not yet recruiting

Fri, 08 Dec 2017 12:00:00 EST


A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
Condition:   Type1 Diabetes Mellitus
Interventions:   Device: AID System;   Drug: Insulin Lispro
Sponsor:   Eli Lilly and Company
Recruiting

Fri, 08 Dec 2017 12:00:00 EST


Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
Conditions:   Atrial Fibrillation;   Anticoagulants;   Clinical Decision Support Systems
Intervention:   Device: CDS-NVAF
Sponsors:   Jordi Gol i Gurina Foundation;   Institut Català de la Salut;   Department of Health, Generalitat de Catalunya
Not yet recruiting

Fri, 08 Dec 2017 12:00:00 EST


Dietary Analyses in the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-Up Study
Conditions:   Type2 Diabetes;   Coronary Artery Disease;   Morality;   Stroke
Intervention:   Other: Dietary assessments
Sponsors:   Harvard School of Public Health;   Harvard Medical School
Completed

Fri, 08 Dec 2017 12:00:00 EST


Interaction of Potassium and Genetic Risk Variants on Diabetes Risk
Condition:   Diabetes
Intervention:  
Sponsors:   Duke University;   Johns Hopkins University;   University of Colorado, Denver;   University of Mississippi Medical Center
Completed

Fri, 08 Dec 2017 12:00:00 EST


Protein Supplementation In Dialysis Patients
Condition:   Peritoneal Dialysis Patients
Interventions:   Dietary Supplement: Ceprolac;   Other: Dietary counseling (DC)
Sponsor:   National University of Malaysia
Completed

Fri, 08 Dec 2017 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
Today, the U.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores – retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements. The “Every Try Counts” campaign targets smokers ages 25-54 who have attempted to quit smoking in the last year but were unsuccessful. The two-year campaign launches next month in 35 U.S. markets and features print, digital, radio, and out-of-home ads, such as on billboards.

Mon, 11 Dec 2017 09:14:00 -0500


Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation
FDA Commissioner Gottlieb testifies before the U.S. Senate Committee on Health, Education, Labor & Pensions on the agency’s implementation of the 21st Century Cures Act

Thu, 07 Dec 2017 10:48:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation
Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Thu, 07 Dec 2017 09:00:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices
The FDA is issuing final guidance on the technical considerations for the 3D printing of medical devices. The recommendations clarify what the FDA recommends manufacturers include in submissions for 3D printed medical products.

Mon, 04 Dec 2017 11:10:00 -0500


FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers

Fri, 01 Dec 2017 10:39:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments
Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

Thu, 30 Nov 2017 18:45:00 -0500


FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

Thu, 30 Nov 2017 18:34:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages
Statement by FDA Commissioner Scott Gottlieb, M.D. on efforts by the agency to address the impact of IV saline products and amino acids for injection shortages following the hurricane and update on FDA’s work in Puerto Rico

Thu, 30 Nov 2017 16:59:00 -0500


FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers
FDA/CMS parallel review process makes test for efficient identification of multiple targeted therapy options available to health care professionals, patients and eligible Medicare beneficiaries‎ sooner

Thu, 30 Nov 2017 16:39:00 -0500


Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH"
FDA Commissioner Gottlieb provides testimony before the House Committee on Energy and Commerce on the agency’s implementation of the 21st Century Cures Act

Thu, 30 Nov 2017 10:32:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News